In vitro evaluation of antithrombogenicity of hybrid-type vascular vessel models based on analysis of the mechanism of blood coagulation

Biomaterials
M KaibaraS Kawakami

Abstract

In vitro evaluation of antithrombogenicity of materials of artificial vascular vessels was carried out based on an analysis of the coagulation mechanism of blood. Coagulation of blood in tubes coated with endothelial cells (ECs) or segmented polyurethane (SPU) was measured by a rheological technique. Coagulation of blood in hybrid-type vascular vessel model tubes consisting of cultured ECs proliferated on carbon-deposited SPU was also examined. Coagulation of blood in these tubes occurred within 40 min, and appears to be due to the interaction between erythrocytes and a coagulant factor in plasma. From the in vitro evaluation test, when the time of onset of the coagulation of blood in contact with a surface of the artificial materials is longer than 20-39 min, the materials can be considered to provide an inert surface against thrombus formation and blood coagulation.

References

May 1, 1979·Microvascular Research·T Karino, H L Goldsmith
Jan 1, 1979·Transactions - American Society for Artificial Internal Organs·P D RichardsonR Kane
Aug 1, 1992·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Y Kawamoto, M Kaibara
Sep 14, 1990·Biochimica Et Biophysica Acta·Y Kawamoto, M Kaibara
May 1, 1972·Journal of Biomedical Materials Research·Y Imai, Y Nose
May 1, 1981·The Journal of Clinical Investigation·C Ingerman-WojenskiE Macarak
Oct 13, 1956·Nature·J MARGOLIS

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.